Russia, Kazakhstan agree on supplies of Russian-made anti-COVID vaccine

Business Materials 26 August 2020 14:04 (UTC +04:00)
Russia, Kazakhstan agree on supplies of Russian-made anti-COVID vaccine

BAKU, Azerbaijan, Aug.26

By Nargiz Sadikhova - Trend:

Russian Direct Investment Fund (RDIF) and Kazakhstan’s SK-Pharmacy have signed an agreement on supplies of Sputnik V anti-COVID vaccine to Kazakhstan, Trend reports with reference to RDIF.

The batch of vaccine for delivery to Kazakhstan will be produced by one of the international partners of RDIF.

On August 11, the vaccine was registered by the Ministry of Health of Russia and can be used to vaccinate the population in Russia. Full-scale production of the vaccine is expected to begin in September.

Russian Direct Investment Fund (RDIF) is Russia's sovereign wealth fund established in 2011 to make equity co-investments, primarily in Russia, alongside reputable international financial and strategic investors. RDIF acts as a catalyst for direct investment in the Russian economy.

RDIF has established joint strategic partnerships with leading international co-investors from more than 18 countries that total more than $40 billion.

The first two cases of coronavirus infection were detected in Kazakhstan among those who arrived in Almaty city from Germany on March 13, 2020.


Follow the author on twitter: @nargiz_sadikh